All Biotech News

List of articles in category All Biotech News
Title	Published Date
BioPharmaSpec Launches New Host Cell Protein Detection Service	02/27/2018
Serious About Serialisation: DCC Vital Selects rfxcel for EU FMD Compliance	02/21/2018
Selvita Announces Successful Completion of $41 M Book Building	02/16/2018
Vetter Is a Winner of the Fraunhofer Clean Manufacturing Award CLEAN! 2018	02/15/2018
Orchard Therapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference	02/13/2018
New ISOLUTE® HYDRO DME+ Rapidly Removes Matrix Interferences from Urine	02/13/2018
ProBioGen and TEVA Sign License Agreement on Human Artificial Lymph Node Technology	02/07/2018
Selvita Appoints Steffen Heeger, M.D., PhD as Chief Medical Officer	02/06/2018
Orchard Therapeutics Appoints Dr. Harry Malech to Scientific Advisory Board	02/05/2018
Vetter Introduces South Korea’s Pharma and Biotech Community to Meet Company Management	02/02/2018
ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results with 3K3A-APC	01/29/2018
Araclon Biotech Partners with TFS International for Their Alzheimer’s Phase II Trial	01/25/2018
FuturaGene's Exclusive License for RNAi Technology in Eucalyptus Enhanced by Grant of Patent in Brazil	01/17/2018
Orchard Therapeutics Appoints Frank Thomas as Chief Financial Officer and Chief Business Officer	01/17/2018
Batavia Biosciences Teams Up with International Consortium to Support Polio Eradication	01/16/2018
BioNTech Announces Results from Two More Studies Demonstrating the Benefits of Breast Cancer Subtyping Using Mammatyper®	01/15/2018
TFS International Appoints New Chief Executive Officer	01/10/2018
WACKER Obtains FDA Approval to Manufacture the Drug Substance in Retavase®, a Thrombolysis Medication by Chiesi	01/09/2018
ANTABIO Announces Key Executive Appointments	01/05/2018
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites in San Diego and Bristol	01/04/2018
Orchard Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference	12/22/2017
rfxcel Approved as a Technically Certified Connection Provider for EMVO	12/21/2017
Orchard Therapeutics Announces $110M Series B Financing to Advance Transformative Gene Therapy Pipeline	12/20/2017
Agendia and Bluebee Partner to Bring New NGS-Based MammaPrint® BluePrint® Breast Cancer Kit to Market	12/19/2017
Orchard Therapeutics and Généthon Announce Gene Therapy Alliance in X-linked Chronic Granulomatous Disease	12/15/2017
FDA Grants Orphan Drug Designation to Zytoprotec's Novel Dialysis Fluid	12/14/2017
Thrombolytic Science Announces the Appointment of Annalisa Jenkins, MBBS, FRCP, as a Non-Executive Board Member	12/14/2017
Key Executives Join the rfxcel Team to Drive Global Growth	12/13/2017
Agendia: Key Studies Presented at the San Antonio Breast Cancer Symposium Demonstrate the Important Role of MammaPrint® for Patient Pre-Selection, Cost-Effectiveness and For Younger Patients	12/12/2017
Dr. Hitto Kaufmann of Sanofi-Aventis and Dr. Eliana Clark of Biogen to Deliver Plenary Keynote Presentations at CHI’s Bioprocessing Summit Europe	12/12/2017

Page 37 of 88